2012 annual financial data

Sonoma Pharmaceuticals 2012 Net margin

Sonoma Pharmaceuticals 2012 net margin with verified reported values.

Direct answer

Net margin was -57.51%.

Operating income was -6,467,000 USD and net income was -7,329,000 USD.
Operating cash flow was -4,032,000 USD.

Get free Sonoma Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
12,744,000 USD
Operating income
-6,467,000 USD
Net income
-7,329,000 USD
Operating cash flow
-4,032,000 USD